AnHeart Therapeutics Revenue and Competitors

Shanghai, NY USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AnHeart Therapeutics's estimated annual revenue is currently $5M per year.(i)
  • AnHeart Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • AnHeart Therapeutics has 32 Employees.(i)
  • AnHeart Therapeutics grew their employee count by -46% last year.

AnHeart Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder & CMOReveal Email/Phone
2
VP Head Medical AffairsReveal Email/Phone
3
SVP & Head Clinical Development StrategyReveal Email/Phone
4
SVP, Head Global Clinical PharmacologyReveal Email/Phone
5
VP, U.S. CommercialReveal Email/Phone
6
Director Clinical OperationsReveal Email/Phone
7
Medical DirectorReveal Email/Phone
8
Co-Founder & Chief Strategy OfficerReveal Email/Phone
9
Senior director, pharmacovigilanceReveal Email/Phone
10
Medical DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M40%N/AN/A
#2
$3.7M2441%$44MN/A
#3
$6.2M40-7%N/AN/A
#4
$42M271-1%N/AN/A
#5
$12.7M820%$10MN/A
#6
$2.5M160%N/AN/A
#7
$7.5M450%$51.6MN/A
#8
$0.2M1-50%N/AN/A
#9
$4.3M26-16%$3.3MN/A
#10
$3.7M244%N/AN/A
Add Company

What Is AnHeart Therapeutics?

AnHeart Therapeutics is an oncology-focused clinical stage biopharmaceutical company headquartered in Hangzhou, China with offices in Beijing, Shanghai and New York. The company’s pipeline consists of three clinical stage assets: Taletrectinib, a next-gen ROS1 and NTRK inhibitor currently in Phase 2; an mIDH1 inhibitor ready for Phase 2 for low grade glioma, cholangiocarcinoma, AML and other tumors; and an AXL inhibitor in Phase 1 for overcoming resistance in various tumors.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$5M

Revenue (est)

-46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.8M32N/AN/A
#2
$3.7M3310%N/A
#3
$8.3M336%N/A
#4
$2M35N/AN/A
#5
$3.6M353%N/A